atorvastatin has been researched along with Angina, Stable in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (92.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Busk, M; Bøtker, HE; Dey, D; Fonte, T; Grove, EL; Hosbond, S; Iraqi, N; Jensen, JM; Leipsic, J; Mathiassen, ON; Mortensen, MB; Narula, J; Nørgaard, BL; Sand, NP; Updegrove, A | 1 |
| Cappelletti, A; Cera, M; Chieffo, A; Colombo, A; Godino, C; Magni, V; Mangieri, A; Margonato, A; Monello, A; Pavon, AG; Salerno, A | 1 |
| Karpov, YA; Lopukhova, VV; Tomilova, DI | 1 |
| Lee, CW; Park, SJ | 1 |
| Chello, M; Coccia, R; Covino, E; De Marco, F; Di Domenico, F; Di Sciascio, G; Lusini, M; Patti, G; Pettinari, M; Pollari, F; Spadaccio, C; Zanzonico, R | 1 |
| Artenjak, A; Cerne, D; Lakota, K; Marc, J; Mirjanic-Azaric, B; Rizzo, M; Sodin-Semrl, S; Sormaz, L; Stojanovic, D; Uletilovic, S | 1 |
| Biondi-Zoccai, G; Calcagno, S; Canali, E; Conti, G; Fedele, F; Lucisano, L; Mancone, M; Pennacchi, M; Sardella, G; Stio, RE | 1 |
| Cerne, D; Djeric, M; Jelic-Ivanovic, Z; Kos, J; Marc, J; Milivojac, T; Mirjanic-Azaric, B; Pecar Fonovic, U; Vekic, J; Zeljkovic, A | 1 |
| Cerne, D; Hallstroem, S; Jürgens, G; Marc, J; Mirjanic-Azaric, B; Rizzo, M; Srdic, S | 1 |
| Chu, Y; Hao, H; Hu, S; Joerg, H; Li, B; Liu, Z; Sang, C; Xia, J; Xu, D; Xu, J | 1 |
| Chen, Q; Liang, L; Shang, X; Yuan, M; Zhong, X | 1 |
| Beckerman, B; Buch, J; Bultas, J; Deanfield, JE; Sellier, P; Shi, H; Thaulow, E; Yunis, C | 1 |
| Ike, A; Iwata, A; Kawamura, A; Miura, S; Nishikawa, H; Saku, K; Sugihara, M; Tanaka, T | 1 |
| Davutoglu, V; Ercan, S; Sari, I | 1 |
6 trial(s) available for atorvastatin and Angina, Stable
| Article | Year |
|---|---|
Influence of intensive lipid-lowering on CT derived fractional flow reserve in patients with stable chest pain: Rationale and design of the FLOWPROMOTE study.
Topics: Angina, Stable; Atorvastatin; Ezetimibe; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Tomography, X-Ray Computed | 2022 |
Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study.
Topics: Aged; Angina, Stable; Atorvastatin; Coronary Artery Disease; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Rosuvastatin Calcium; Time Factors; Treatment Outcome | 2017 |
Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
Topics: Aged; Angina, Stable; Atorvastatin; Elective Surgical Procedures; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Necrosis; Percutaneous Coronary Intervention; Postoperative Complications; Preoperative Care; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2013 |
Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
Topics: Acute Coronary Syndrome; Aged; Angina, Stable; Atorvastatin; China; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lipids; Liver Function Tests; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Treatment Outcome; Troponin I | 2016 |
Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease.
Topics: Acute Coronary Syndrome; Aged; Angina, Stable; Atorvastatin; China; Coronary Artery Disease; Cytokines; Dose-Response Relationship, Drug; Female; GPI-Linked Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lectins; Male; Middle Aged; Time Factors; Treatment Outcome; Up-Regulation | 2017 |
Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?
Topics: Aged, 80 and over; Amlodipine; Angina, Stable; Antihypertensive Agents; Atorvastatin; Chronic Disease; Double-Blind Method; Drug Combinations; Electrocardiography, Ambulatory; Exercise Test; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Middle Aged; Myocardial Ischemia; Pyrroles; Young Adult | 2010 |
8 other study(ies) available for atorvastatin and Angina, Stable
| Article | Year |
|---|---|
[Long-Term Statin Adherence in Patients with Stable Angina after Coronary Stenting].
Topics: Angina, Stable; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Rosuvastatin Calcium; Treatment Outcome | 2018 |
Statins for treating stable angina: can statins improve the plaque morphology and angina?
Topics: Angina Pectoris; Angina, Stable; Atorvastatin; Disease Progression; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plaque, Atherosclerotic; Pravastatin; Pyrroles; Ultrasonography, Interventional | 2013 |
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
Topics: Aged; Angina, Stable; Atorvastatin; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Diabetes Complications; Drug-Eluting Stents; Female; Glycation End Products, Advanced; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Pyrroles; ROC Curve; Tubulin Modulators | 2013 |
Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: pleiotropic evidence from plasma mRNA analyses.
Topics: Aged; Angina, Stable; Anticholesteremic Agents; Atorvastatin; Chemokine CCL2; Cholesterol, LDL; Drug Administration Schedule; Female; Gene Expression; Heptanoic Acids; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Pyrroles; RNA, Messenger | 2013 |
Interrelated cathepsin S-lowering and LDL subclass profile improvements induced by atorvastatin in the plasma of stable angina patients.
Topics: Angina, Stable; Anticholesteremic Agents; Atorvastatin; Biomarkers; Blotting, Western; Cathepsins; Cholesterol, HDL; Cholesterol, LDL; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heptanoic Acids; Humans; Male; Middle Aged; Prognosis; Pyrroles; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2014 |
Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients.
Topics: Angina, Stable; Atorvastatin; Bilirubin; Female; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Humans; Male; Middle Aged; Proteolysis; RNA, Messenger | 2015 |
Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
Topics: Aged; Angina, Stable; Atorvastatin; Biomarkers; C-Reactive Protein; Case-Control Studies; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Down-Regulation; Female; Fibrosis; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Lipids; Male; Middle Aged; Plaque, Atherosclerotic; Predictive Value of Tests; Pyrroles; Serum Amyloid P-Component; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Uric Acid | 2012 |
Dramatic regression of three-vessel disease under statin treatment in patients with stable angina pectoris.
Topics: Angina, Stable; Atorvastatin; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pyrroles; Treatment Outcome | 2012 |